Table 1. Efficacy of benznidazole (Bz) and posaconazole (Ps) treatments for 7 days (monotherapy or combination) in murine model of acute Trypanosoma cruzi infection1.
Experimental groups | Parasitemia clearance (doses) | Number of surviving/total number of animals | Maximum level of parasitemia until 30 days after treatment×103 (mean±SD) |
Uninfected | - | 6/6 | - |
Untreated | - | 0/6 | 1,424.6±507.1 |
Bz 100 mg/Kg/day | 1.83±0.75 | 6/6 | 95.6±46.8 |
Ps 20 mg/Kg/day | 1.5±0.54 | 6/6 | 74.8±38.1 |
Bz+Ps (100+20 mg/Kg/day) | 1.0±0 | 6/6 | 13.2±3.9* |
Bz 50 mg/Kg/day | 1.33±0.51 | 4/6 | 174.8±192.8 |
Ps 10 mg/Kg/day | 1.17±0.41 | 6/6 | 101.2±1,102.5 |
Bz+Ps (50+10 mg/Kg/day) | 1.4±0.55 | 5/6 | 20.1±99.6* |
Bz 25 mg/Kg/day | ND | 2/6 | 418.6±518.23 |
Ps 5 mg/Kg/day | 1.17±0.41 | 4/6 | 240.2±338.2 |
Bz+Ps (25+5 mg/Kg/Day) | 1.16±0.41 | 6/6 | 36.6±28.4* |
Swiss female (n = 6) weight 20 to 24 g were inoculated with 5×103 trypomastigotes (Ystrain).
Treatment was started at 4th day after inoculation followed by 7 daily doses and the drugs were administered orally.
Significant difference in relation to benznidazole monotherapy treatment at same dose.
ND – Not detected.